Rani Therapeutics Holdings Class ARANI
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 31 institutions reported holding Rani Therapeutics Holdings Class A (RANI) in their 13F filings, down 3 from Q2 2024. 3 opened new positions and 7 sold out. The largest holders were Armistice Capital, LLC ($5.6M), Vanguard Group Inc. ($1.5M) and Nan Fung Group Holdings Ltd ($1.1M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Rani Therapeutics Holdings Class A
- CUSIP
- 753018100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $5.6M |
| Exits | 7 | $125K |
All 13F filers, Q2 2024 → Q3 2024: 2,887,450 shares bought and 84,866 shares sold, net +2,802,584 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Armistice Capital, LLC | 0.15% | New | 2,574,000 | $5.6M |
| Vanguard Group Inc. | 0.00% | No change | 709,828 | $1.5M |
| Nan Fung Group Holdings Ltd | 0.92% | No change | 493,584 | $1.1M |
| Alphabet Inc. | 0.05% | No change | 448,492 | $969K |
| United Services Automobile Association | 0.02% | Reduce -3.0% | 302,743 | $654K |
| Stifel Financial Corp. | 0.00% | Add +100.4% | 269,768 | $583K |
| Takeda Pharmaceutical Co. Ltd. | 1.16% | Reduce -5.6% | 203,190 | $439K |
| Geode Capital Management, LLC | 0.00% | Add +14.3% | 172,261 | $372K |
| Northern Trust Corp. | 0.00% | Add +199.2% | 105,634 | $228K |
| King Luther Capital Management Corp. | 0.00% | Add +44.5% | 81,129 | $175K |
| Bank of America Corp. | 0.00% | Reduce -17.1% | 76,145 | $164K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 71,500 | $154K |
| BlackRock, Inc. | 0.00% | — | 63,583 | $137K |
| Lasry Marc | 0.25% | No change | 62,887 | $136K |
| Motco | 0.01% | No change | 48,129 | $104K |
| State Street Corp. | 0.00% | No change | 42,042 | $91K |
| Renaissance Technologies | 0.00% | Add +53.0% | 33,199 | $72K |
| Brown Advisory Inc. | 0.00% | No change | 32,911 | $71K |
| Citadel Advisors | 0.00% | Add +82.2% | 26,904 | $58K |
| Lafayette Investments, Inc. | 0.01% | No change | 19,893 | $43K |
| UBS Group AG | 0.00% | Add +423.6% | 15,709 | $34K |
| Prime Capital Investment Advisors, LLC | 0.00% | Reduce -17.3% | 11,485 | $25K |
| Millennium Management | 0.00% | New | 11,447 | $25K |
| Cerity Partners LLC | 0.00% | New | 10,000 | $22K |
| Islay Capital Management, LLC | 0.01% | No change | 9,611 | $21K |
| Morgan Stanley | 0.00% | Add +77.9% | 5,251 | $11K |
| Allworth Financial LP | 0.00% | No change | 3,119 | $7K |
| Simplex Trading, LLC | 0.00% | Add +91.3% | 2,835 | $6K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 2,000 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -88.1% | 1,721 | $4K |
| JPMorgan Chase & Co. | 0.00% | No change | 71 | $153 |
"% of holder's portfolio" is RANI's weight in each manager's 13F, not the share of Rani Therapeutics Holdings Class A the manager owns.